Article
Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations.
Clinical breast cancer - 1 Oct 2004
Robson Mark
Abstract excerpt
Women with germline mutations in BRCA1 or BRCA2 are known to be at substantially elevated risk for breast cancer. With increasing acceptance of genetic testing, significant numbers of mutation carriers are being identified, but evidence-based guidelines for the management of women at hereditary risk are lacking. This article reviews the most commonly recommended modalities employed in breast cancer surveillance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
